Broad Institute

Broad Metabolism Program scientists harness several technologies, including next-generation sequencing and metabolic profiling, to define the genetic and metabolic basis of rare diseases, with a focus on mitochondrial illness. These scientists are identifying new targets and therapeutic strategies for these devastating disorders.